Clinical Trial Update: Spironolactone in Atrial Fibrillation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for spironolactone in atrial fibrillation is reported, status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: University of Birmingham | Conditions: Atrial Fibrillation | Phase 4 | Status: UNKNOWN